UK markets close in 2 hours 26 minutes

Xvivo Perfusion AB (publ) (XVIVOS.XC)

Cboe UK - Cboe UK Real-time price. Currency in SEK
Add to watchlist
320.750.00 (0.00%)
As of 08:56AM BST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
369,641
597,542
415,292
258,386
179,861
Cost of revenue
104,552
152,431
118,336
70,107
50,131
Gross profit
265,089
445,111
296,956
188,279
129,730
Operating expenses
Research development
60,860
135,942
69,343
54,039
66,740
Selling general and administrative
211,134
309,205
223,377
153,375
107,708
Total operating expenses
269,528
439,715
292,501
207,021
173,916
Operating income or loss
-4,439
5,396
4,455
-18,742
-44,186
Interest expense
-
1,190
605
276
361
Income before tax
29,800
94,521
22,314
6,665
-57,263
Income tax expense
-82
2,701
3,887
-1,487
-13,528
Income from continuing operations
29,882
91,820
18,427
8,152
-43,735
Net income
29,882
91,820
18,427
8,152
-43,735
Net income available to common shareholders
29,882
91,820
18,427
8,152
-43,735
Basic EPS
0.62
3.07
0.62
0.28
-1.61
Diluted EPS
0.62
3.07
0.62
0.28
-1.61
Basic average shares
29,526
29,935
29,526
28,846
27,171
Diluted average shares
29,526
29,935
29,526
28,936
27,355